Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 26, 2021 09:00 ET | Source: Generex Biotechnology Corp.

Generex Biotechnology Corporation Subsidiary, Olaregen Therapeutix Announces its Malaysian Distribution Partner, Nexgen Medical, has gained approval for the use of Excellagen® Wound Conforming Matrix from The Malaysian Ministry of Health, its country’s equivalent to the U.S. FDA

MIRAMAR, Fla., July 26, 2021 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) subsidiary Olaregen Therapeutix announced in May that the company has executed a...
June 22, 2021 10:17 ET | Source: Generex Biotechnology Corp.

NuGenerex Immuno-Oncology Secures $535 Million Valuation from World-Class Independent Valuation & Appraisal Firm

Ii-Key Immunotherapeutic Vaccine TechnologyIi-Key-SARS-CoV-2 Vaccine Market Potential & International ContractsMarket Potential for AE37 (Ii-Key-HER2) Immunotherapeutic Vaccine for breast,...
May 11, 2021 09:00 ET | Source: Generex Biotechnology Corp.

Generex Biotechnology Subsidiary NuGenHealth Contracts with Westside Medicine & Cardiology, Inc. to Provide Remote Patient Monitoring (RPM) Services

NuGenHealth Software as a Service (SaaS) platform that enables their clients to monitor the health and wellbeing of their patient population.Westside Medicine & Cardiology, Inc. is a professional...
May 10, 2021 09:00 ET | Source: Generex Biotechnology Corp.

Generex Posts Recording of May 6 Shareholder Conference Call Highlighting its Ii-Key COVID Complete Vaccine™ and its Go-Forward Plans for Revenue Producing Assets

Update on Ii-Key-SARS-CoV-2 vaccine programAppointment of Dr. Craig Eagle to be Chairman of the Board of NuGenerex Immuno-Oncology Inc. pending board approval.Re-Launch of Excellagen® in the VA...
May 06, 2021 08:30 ET | Source: Generex Biotechnology Corp.

Generex Biotechnology Subsidiary NuGenHealth Contracts with Florida Health Care Associates to Provide Remote Patient Monitoring (RPM) Services

NuGenHealth Software as a Service (SaaS) platform that enables their clients to monitor the health and wellbeing of their patient population.Florida Health Care Associates is a professional...
May 05, 2021 12:20 ET | Source: Generex Biotechnology Corp.

Generex Provides Clarification on Its Ii-Key COVID-19 Complete Vaccine China Partnership Agreement

MIRAMAR, Fla., May 05, 2021 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (“Generex” or the “Company”), an innovative and integrated healthcare holding company...
May 04, 2021 13:12 ET | Source: Generex Biotechnology Corp.

Generex Biotechnology Announces Call-in Details and Agenda for Shareholder Conference Call on Thursday May 6, 2021 at 9:00 AM

MIRAMAR, Fla., May 04, 2021 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (“Generex” or the “Company”), an innovative and integrated healthcare holding company...
May 03, 2021 09:00 ET | Source: Generex Biotechnology Corp.

Generex Biotechnology Subsidiary Olaregen Therapeutix Announces Agreement with Nexgen Medical for Distribution of Excellagen® Wound Conforming Matrix in Malaysia

MIRAMAR, Fla., May 03, 2021 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) subsidiary Olaregen Therapeutix today announced that the company has executed a...
April 27, 2021 08:30 ET | Source: Generex Biotechnology Corp.

Generex Provides Update on its Ii-Key COVID-19 Complete Vaccine Program: Advancing Global Development

Generex receives $2 million payment from Chinese partners to provide research results, data, and necessary documents to support an IND submission to the Chinese National Medical Products...
April 12, 2021 08:00 ET | Source: Generex Biotechnology Corp.

NuGenerex Immuno-Oncology Submits Protocol, Data, and Manufacturing Information to FDA in Advance of the IND Submission

Response to Pre-IND CommentsPre-clinical and ex-vivo resultsGMP ManufacturingAdjuvant dataRevised protocol as per FDA recommendations MIRAMAR, Fla., April 12, 2021 (GLOBE NEWSWIRE) -- NuGenerex...